Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

NCT01131312 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01131312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 3
Overall status
Completed
Start date
February 20, 2008
Completion date
February 5, 2009
Enrollment
5,060 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia